Chronic Inflammation and Susceptibility to Bacterial Infections in Mice Lacking the Polypeptide (p)105 Precursor (NF-κB1) but Expressing p50

The polypeptide (p)50 molecule, a subunit of nuclear factor (NF)-κB, is produced after proteolytic processing of the p105 precursor (NF-κB1). Although the p105 precursor has been postulated to play a role in the regulation of the Rel/NF-κB activity, its physiological relevance remains unclear. To investigate that, we generated mutant mice lacking the COOH terminal half of the p105 precursor, but expressing the p50 product (p105−/−). These mutant mice displayed an inflammatory phenotype composed of lymphocytic infiltration in lungs and liver, and an increased susceptibility to opportunistic infections. Enlargement of multiple lymph nodes, splenomegaly due to erythrocytic extramedullary hematopoiesis, and lymphoid hyperplasia were also observed in p105−/− mice. Cytokine production in p105−/− macrophages was severely impaired, whereas proliferative responses of p105−/− B cells were increased. T cell functions were only moderately impaired in mutant mice. Loss of p105 also led to enhanced constitutive p50 homodimer and inducible NF-κB activities in unstimulated and stimulated cells, respectively. As several genes regulated by Rel/NF-κB were upregulated in p105−/− thymus but downregulated in p105−/− macrophages, the enhanced p50 homodimers appear to function as transcriptional activators or repressors, depending on the cell type. Thus, the p105 precursor is indispensable in the control of p50 activity, and lack of the precursor has distinct effects on different cells.

[1]  A. Feller,et al.  Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene , 1993, Cell.

[2]  W. Schaffner,et al.  Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. , 1989, Nucleic acids research.

[3]  C. Mueller-Dieckmann,et al.  Tyrosine Phosphorylation of IkB-a Activates NF-kB without Proteolytic Degradation of IkB-a , 1996 .

[4]  A. Sher,et al.  Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions. , 1997, Immunity.

[5]  P. Baeuerle,et al.  Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.

[6]  G. Franzoso,et al.  Structure, regulation and function of NF-kappa B. , 1994, Annual review of cell biology.

[7]  D. Carrasco,et al.  Constitutive and inducible Rel/NF-kappa B activities in mouse thymus and spleen. , 1994, Oncogene.

[8]  W. Greene,et al.  Autoregulation of the NF-kappa B transactivator RelA (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[9]  A. Baldwin,et al.  The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors. , 1993, Genes & development.

[10]  E M Schwarz,et al.  Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. , 1995, Genes & development.

[11]  D. Carrasco,et al.  Expression of relB transcripts during lymphoid organ development: specific expression in dendritic antigen-presenting cells. , 1993, Development.

[12]  A. Israël,et al.  I kappa B epsilon, a novel member of the IκB family, controls RelA and cRel NF‐κB activity , 1997 .

[13]  E. Coligan.  Current protocols in immunology , 1991 .

[14]  D. Lo,et al.  Expression of relB is required for the development of thymic medulla and dendritic cells , 1995, Nature.

[15]  G. Dranoff,et al.  Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. , 1994, Science.

[16]  C. Stewart,et al.  IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice , 1996, Molecular and cellular biology.

[17]  P. Dobrzanski,et al.  Differential interactions of Rel‐NF‐kappa B complexes with I kappa B alpha determine pools of constitutive and inducible NF‐kappa B activity. , 1994, The EMBO journal.

[18]  G. Nossal,et al.  Functional and molecular characterization of single, (4‐hydroxy‐3‐nitrophenyl)acetyl (NP)‐specific, IgG1+ B cells from antibody‐secreting and memory B cell pathways in the C57BL/6 immune response to NP , 1992, European journal of immunology.

[19]  E. Kopp,et al.  NF-kappa B and rel proteins in innate immunity. , 1995, Advances in immunology.

[20]  D. Baltimore,et al.  B cells from p50/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching. , 1996, Journal of immunology.

[21]  Tom Maniatis,et al.  The ubiquitinproteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB , 1994, Cell.

[22]  M. Grilli,et al.  NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. , 1993, International review of cytology.

[23]  T. Maniatis,et al.  NF-κB: A lesson in family values , 1995, Cell.

[24]  I. Verma,et al.  Immunological defects in mice with a targeted disruption in Bcl-3. , 1997, Genes & development.

[25]  D. Baltimore,et al.  The NF‐kappa B p50 precursor, p105, contains an internal I kappa B‐like inhibitor that preferentially inhibits p50. , 1992, The EMBO journal.

[26]  M. Karin,et al.  p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction. , 1993, Genes & development.

[27]  F. Weih,et al.  Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family , 1995, Cell.

[28]  David M. Rothwarf,et al.  A cytokine-responsive IκB kinase that activates the transcription factor NF-κB , 1997, Nature.

[29]  David Baltimore,et al.  Regulation of the NF-?B/rel transcription factor and I?B inhibitor system , 1993 .

[30]  C. Mueller-Dieckmann,et al.  Tyrosine Phosphorylation of IκB-α Activates NF-κB without Proteolytic Degradation of IκB-α , 1996, Cell.

[31]  A. Baldwin,et al.  Mechanistic aspects of NF-κB regulation: The emerging role of phosphorylation and proteolysis , 1995 .

[32]  T. Wirth,et al.  Distinct NF-κB/Rel transcription factors are responsible for tissue-specific and inducible gene activation , 1993, Nature.

[33]  David D. Chaplin,et al.  Role of Lymphotoxin and the Type I TNF Receptor in the Formation of Germinal Centers , 1996, Science.

[34]  T. Maniatis,et al.  Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. , 1995, Genes & development.

[35]  Inder M. Verma,et al.  R~~/NF-KB /IKB familv: intimate tales of association and dissociation , 1995 .

[36]  I. Verma,et al.  Rel/NF-kappa B/I kappa B story. , 1995, Advances in cancer research.

[37]  D. Carrasco,et al.  The v‐rel oncogene promotes malignant T‐cell leukemia/lymphoma in transgenic mice. , 1996, The EMBO journal.

[38]  R. Roeder,et al.  Transcriptional regulation of the HIV-1 promoter by NF-kappa B in vitro. , 1992, Genes & development.

[39]  P. Morin,et al.  The IκB proteins: members of a multifunctional family , 1993 .

[40]  D. Carrasco,et al.  Gastric Hyperplasia and Increased Proliferative Responses of Lymphocytes in Mice Lacking the COOH-terminal Ankyrin Domain of NF-κB2 , 1997, The Journal of experimental medicine.

[41]  S. Miyamoto,et al.  REL/NF-?B/I?B Story , 1995 .

[42]  D. Baltimore,et al.  Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice. , 1995, Genes & development.

[43]  J. Dijkstra,et al.  Production of Antiserum , 1998 .

[44]  C. Scheidereit,et al.  The NF‐kappa B precursor p105 and the proto‐oncogene product Bcl‐3 are I kappa B molecules and control nuclear translocation of NF‐kappa B. , 1993, The EMBO journal.

[45]  G. Nolan,et al.  The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers. , 1993, Genes & development.

[46]  A. Strasser,et al.  Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. , 1995, Genes & development.

[47]  G. Nabel,et al.  Proposed NF-κB/IκB family nomenclature , 1993 .

[48]  G. Nolan,et al.  Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B. , 1992, Genes & development.

[49]  A. Israël,et al.  The precursor of NF-κB p50 has IκB-like functions , 1992, Cell.

[50]  R. Bravo,et al.  Molecular Mechanisms of TNFa Cytotoxicity: Activation of NF-?B and Nuclear Translocation , 1996 .

[51]  D. Carrasco,et al.  Developmental expression of the mouse c-rel proto-oncogene in hematopoietic organs. , 1994, Development.

[52]  David Baltimore,et al.  Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses , 1995, Cell.

[53]  David Baltimore,et al.  Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB , 1995, Nature.

[54]  R. Bravo,et al.  Characterization of ES cells deficient for the p105 precursor (NF-kappa B1): role of p50 NLS. , 1996, Oncogene.

[55]  T. Maniatis,et al.  Site-Specific Phosphorylation of IκBα by a Novel Ubiquitination-Dependent Protein Kinase Activity , 1996, Cell.

[56]  U. Sieben,et al.  STRUCTURE, REGULATION AND FUNCTION OF NF-1d3 , 1994 .

[57]  V. Bours,et al.  The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers , 1993, Cell.

[58]  R. Bravo,et al.  Overexpression of RelA in Transgenic Mouse Thymocytes : Specific Increase in Levels of the Inhibitor Protein I k B a , 1995 .

[59]  R. Bravo,et al.  Overexpression of RelA in transgenic mouse thymocytes: specific increase in levels of the inhibitor protein I kappa B alpha , 1995, Molecular and cellular biology.

[60]  I. Verma,et al.  IκBγ, a 70 kd protein identical to the C-terminal half of p110 NF-κB: A new member of the IκB family , 1992, Cell.